|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
1/2026
vol. 101 abstract:
Review paper
Metabolic disruption in early life: the role of endocrine disruptors in pediatric obesity
Jakub Kleinrok
1
,
Weronika Pająk
1
,
Joanna Pec
2
,
Jan Wojtas
2
,
Jacek Baj
2
Pediatr Pol 2026; 101 (1): 73-80
Online publish date: 2026/03/30
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Child and adolescent obesity is a significant and increasingly prevalent public health challenge. Among the contributing factors are endocrine-disrupting chemicals (EDC), which interfere with pathways regulating adipogenesis and metabolic homeostasis. The mechanism of EDC action includes epigenetic modifications, interactions with hormonal receptors, and disruption of key hormones such as leptin, insulin, and thyroid hormones. Exposure during critical developmental periods – specifically in utero and in early childhood – poses a substantial risk, promoting long-term metabolic disorders. This review presents current epidemiological data and discusses potential mechanisms underlying obesity development due to EDC. It also underscores the importance of preventive strategies, including reduced plastic usage, promotion of organic diets, and strengthened regulatory measures, in mitigating the global burden of pediatric obesity.
keywords:
endocrine disruptors, obesogens, childhood obesity, pediatric endocrinology |
POLSKI
